After setbacks in recent times, 2020 could be the year that the first microbiome-based therapy is approved by the US Food and Drug Administration.
A handful of companies are developing new oral therapies containing a controlled formulation of “gut friendly” live bacteria, with the...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?